SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 51 filers reported holding SUTRO BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214,000 | -25.4% | 61,778 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $287,000 | +0.7% | 61,778 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $285,000 | -42.9% | 61,778 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $499,000 | +18.5% | 61,778 | -18.5% | 0.00% | 0.0% |
| Q3 2022 | $421,000 | +6.6% | 75,800 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $395,000 | +19.7% | 75,800 | +88.7% | 0.00% | +100.0% |
| Q1 2022 | $330,000 | +137.4% | 40,174 | +528.8% | 0.00% | 0.0% |
| Q4 2020 | $139,000 | +117.2% | 6,389 | 0.0% | 0.00% | – |
| Q3 2020 | $64,000 | +28.0% | 6,389 | 0.0% | 0.00% | – |
| Q2 2020 | $50,000 | -23.1% | 6,389 | 0.0% | 0.00% | – |
| Q1 2020 | $65,000 | +16.1% | 6,389 | +25.8% | 0.00% | – |
| Q4 2019 | $56,000 | +21.7% | 5,080 | 0.0% | 0.00% | – |
| Q3 2019 | $46,000 | -20.7% | 5,080 | 0.0% | 0.00% | – |
| Q2 2019 | $58,000 | 0.0% | 5,080 | 0.0% | 0.00% | – |
| Q1 2019 | $58,000 | – | 5,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $33,918,000 | 14.78% |
| Samsara BioCapital, LLC | 1,675,579 | $31,149,000 | 3.84% |
| First Light Asset Management, LLC | 2,072,875 | $38,535,000 | 2.31% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,253,000 | 1.88% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $18,616,000 | 1.72% |
| Opaleye Management Inc. | 496,900 | $9,237,000 | 1.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,590,000 | 0.68% |
| Parkman Healthcare Partners LLC | 163,389 | $3,037,000 | 0.66% |
| Eventide Asset Management | 2,370,975 | $44,076,000 | 0.59% |
| BVF INC/IL | 826,825 | $15,371,000 | 0.58% |